|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2005-5-10
|
|
pubmed:abstractText |
Laboratory evidence of cholesterol-induced production of amyloid beta as a putative neurotoxin precipitating Alzheimer disease, along with epidemiological evidence, suggests that cholesterol-lowering statin drugs may favorably influence the progression of the disorder.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0003-9942
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
62
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
753-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15883262-Aged,
pubmed-meshheading:15883262-Aged, 80 and over,
pubmed-meshheading:15883262-Alzheimer Disease,
pubmed-meshheading:15883262-Anticholesteremic Agents,
pubmed-meshheading:15883262-Cholesterol,
pubmed-meshheading:15883262-Double-Blind Method,
pubmed-meshheading:15883262-Female,
pubmed-meshheading:15883262-Heptanoic Acids,
pubmed-meshheading:15883262-Humans,
pubmed-meshheading:15883262-Male,
pubmed-meshheading:15883262-Mental Status Schedule,
pubmed-meshheading:15883262-Neuropsychological Tests,
pubmed-meshheading:15883262-Placebos,
pubmed-meshheading:15883262-Pyrroles,
pubmed-meshheading:15883262-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.
|
|
pubmed:affiliation |
Author Affiliations: Sun Health Research Institute, Sun City, AZ 85351, USA. larry.sparks@sunhealth.org
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
